SILO
SILO
NASDAQ · Biotechnology

Silo Pharma Inc

$0.36
+0.02 (+6.22%)
As of Mar 31, 5:00 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +5,363.0% upside
Low Target $13.54
Average Target $19.88
High Target $24.91
Current Price $0.36
Current
$0.36
Target
$19.88
$13.54 $19.88 avg $24.91
Scenario Analysis
Bear Case
$13.54
3,620.8%
Low target
Base Case
$19.88
+5,363.0%
Avg target
Bull Case
$24.91
+6,745.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.39
-73.8% from high
52-Week Low
$0.22
+64.7% from low
Target vs 52W High
$19.88
+1,329.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%